Aposense Partnerships & Collaborations



Teva Pharmaceuticals

   Co-development of targeted anti-cancer therapies based on conjugating generic cytotoxic agents with Aposense probes for specific delivery to the tumor site.

Press Release

 


 
IBA (Ion Beam Applications) S.A.

  
Strategic collaboration for the global development production and commercialization of ML-10 Apoptosis PET imagining agent

Radio-labeling and distribution of labeled ML-10 to sites participating in multi-center clinical trials.

Press Release


 
Sigma-Aldrich

   Licensing and distribution of ApoTrace™, a probe developed by Aposense for in vivo molecular imaging of apoptosis in preclinical research.

Press Release

Given the wide range of applications for its platform technology, Aposense is considering opportunities for collaboration with partners from industry, government and academia in different areas, including the following:

  • Novel therapeutics based on targeting apoptotic cells
  • Accelerating drug development through molecular imaging of apoptosis
  • Distribution
  • Clinical Trials

To contact a Business Development representative, please write to Aposense at: bizdev@aposense.com.